Results 171 to 180 of about 154,650 (346)
Alcoholic liver disease: State-of-the-art
The literature review gives the present views of the diagnosis and treatment of alcoholic liver disease (ALD) and data on the genetic markers associated with the development of ALD and alcohol addiction.
I V Maev +3 more
doaj
The prevalence of metabolic dysfunction-associated steatotic liver disease (MASLD), a leading cause of chronic liver disease, has increased worldwide along with the epidemics of obesity and related dysmetabolic conditions characterized by impaired ...
Bruno Ramos-Molina +16 more
doaj +1 more source
Pharmacological effects of gastrodin include prevention and treatment of cognitive decline and reperfusion injuries, anticonvulsion, antiepilepsy, antidepressants, and analgesia, which are related to antiferroptosis and antipyroptosis. Abstract Gastrodin, as an effective monomer of gastrodia elata, plays a significant role in anti‐inflammatory ...
Xue Zheng, Jing Li, Zhao‐Qiong Zhu
wiley +1 more source
Inhibition of connexin hemichannels alleviates non-alcoholic steatohepatitis in mouse
Inhibition of connexin hemichannels alleviates non-alcoholic steatohepatitis in ...
B Cogliati (13303395) +11 more
core
Physical Activity and Risk of Liver Cancer: A Competing Risk Analysis
ABSTRACT Physical activity is associated with lower risk of liver cancer, but obtaining an unbiased estimate of the causal effect is challenging due to the competing risk of death due to any other cause. We performed a causal competing risk analysis to estimate the total effect of physical activity on risk of liver cancer in the presence of competing ...
Frances E. M. Albers +9 more
wiley +1 more source
BackgroundPatients with chronic intestinal failure (CIF) dependent on parenteral nutrition (PN) are at risk of developing parenteral nutrition-associated hepatic steatosis (PNAHS), a condition that can progress to hepatic fibrosis.
Yufei Xia +13 more
doaj +1 more source
Metformin in the treatment of patients with non-alcoholic steatohepatitis
Background: Increased insulin resistance is the major pathogenic mechanism in the development of non-alcoholic ...
Z. Yesilova +17 more
core +1 more source
ATP Citrate Lyase in Metabolic Disease: Mechanistic Insights and Clinical Potential
ATP citrate lyase (ACLY) is a central metabolic hub that diverts mitochondrial citrate to fuel de novo lipogenesis, cholesterol biosynthesis, and protein acetylation. Given its robust correlation with pathological changes in multiple human diseases, ACLY inhibitors featuring distinct pharmacological strengths have been developed for therapeutic ...
Wenbiao Wang +5 more
wiley +1 more source
The prevalence of liver disease is steadily increasing worldwide. Meanwhile, metabolic dysfunction-associated steatotic liver disease (MASLD) has become the most prevalent chronic liver disease globally, characterized by the extensive involvement of ...
Sandra Armas-Téllez +3 more
doaj +1 more source
Objectives: Systemic low-grade inflammation is associated with steatohepatitis in adults. We aim to explore if systemic low-grade inflammation, measured by plasma high-sensitivity C-reactive protein (hs-CRP), is also linked to steatotic liver disease in ...
Johannes Nairz +4 more
doaj +1 more source

